This content is provided by Chambers. Learn more about our methodology
What the team is known for Enviable life sciences and technology practice, representing some of the fastest-growing startups in the country on capital markets transactions. Maintains a comprehensive overview of the market, working with companies and investment banks on sophisticated equity offerings, showing considerable strength in IPOs.
Strengths"They did an amazing job," says a client, who refers to the team as "a very talented and super responsive group of lawyers."
A further source says: "Cooley is doing a lot of smart things such as capturing market share in the technology sector and hiring very talented partners," adding: "They're very good on billing and one of the top firms for convertible bonds and equity derivatives."
Work highlights Advised Uber on its $8.1 billion IPO and $1.2 billion convertible notes offering.
Andrew Williamson regularly advises industry-leading clients on major IPOs and follow-on debt and equity offerings. One source calls him a "very strong lawyer and a great leader."
Charlie Kim is best known for his expertise in the life sciences and technology sectors, where he frequently advises underwriters and issuers on IPOs and debt offerings. A client says: "I thought he was terrific. He's smart, pragmatic, responsive and engaged. I'll definitely use him again in the future."
David Peinsipp is recognized for his standout experience handling high-value IPOs and major debt offerings on behalf of technology and life sciences companies. "He was amazing," says one client, who states: "He is exceptional on capital markets, very user-friendly and very responsive. The ball never drops with him."
Div Gupta is a noted expert in the handling of equity transactions, offering particular experience in the biopharmaceutical sector. "He is very experienced and highly sought after as a figure in this marketplace," reports one interviewee.
Eric Jensen is a recommended choice of counsel for major IPOs and debt offerings. He represents issuers and underwriters on a broad range of capital markets transactions. A source says: "He is extremely commended, committed and a very good lawyer."
Eric Blanchard is highlighted by peers as a "very strong driving force" behind the firm's capital markets practice. He routinely advises issuing companies and underwriters on investment debt and equity offerings in the life sciences industry. A client reports: "He has been absolutely brilliant. He is relaxed, measured, on top of all the issues and a delight to deal with."